Most vulnerable HCV patient groups treated with direct acting antivirals achieve high response rates and gain quality of life – Data from the German Hepatitis C-Registry (DHC-R) - Christensen, S.; Stoehr, A.; Teuber, G.; Petersen, J.; Link, R.; Naumann, U.; John, C.; Simon, K.-G.; Serfert, Y.; Zeuzem, S.; Wedemeyer, H. (Zeitschrift für Gastroenterologie, 2023)